ICS 2012 Report – The world’s first fully implantable artificial heart has been designed three decades after the world’s first human heart transplant
by Edel O’Connell reporting on the presentation by Professor Alain Carpentier.
by Edel O’Connell reporting on the presentation by Professor Alain Carpentier.
by Bruce Sylvester – Emerging use of FDA Approved Drugs – Maraviroc, an antiretroviral drugin the treatment of HIV, significantly reduces the incidence of graft-versus-host disease (GvHD) among… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – In some patients severe aplastic anemia who have failed standard therapies, eltrombopag appears to raise blood cell… read more.
by Maria Dalby – Biopsies taken one year after renal transplantation could be used for identifying patients at high risk of graft failure.
by Maria Dalby – Efforts continue to develop new anti-rejection agents that are as effective as the calcineurin inhibitors (CNI) but without the debilitating side effects.
by Maria Dalby – Almost all lung transplant recipients will develop bronchiolotis obliterans (BO) if they live long enough – as transplantation care is improving, BO is becoming… read more.
Details of prizes/awards at the 24th International Congress of the Transplantation Society
by Maria Dalby – Donating a kidney in later life can have a positive effect on quality of life, according to the largest study to date on this… read more.
by Maria Dalby – The first face transplantation to be performed in the USA took place at the Cleveland Clinic in December 2008.
by Maria Dalby – It is possible to modulate the body’s immune system by altering the gut microbiota, simply by changing the diet.
by Maria Dalby – That the human brain is capable of reorganising itself following the loss of a limb is well known – the part of the motor… read more.
by Maria Dalby – Patients undergoing simultaneous pancreas and kidney (SPK) transplantation where the drainage is led to the bladder are more likely to suffer acute rejection episodes… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.